Minimal Heparin Cofactor Activity in Disseminated Intravascular Coagulation and Cirrhosis
- 1 September 1976
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 66 (3) , 488-494
- https://doi.org/10.1093/ajcp/66.3.488
Abstract
An assay technic for measuring heparin cofactor activity in which antithrombin activity can be assessed without plasma attenuation even in the presence of therapeutic levels of heparin is presented. Heparin-activated anti-thrombin activity was markedly depressed in plasmas of four patients with disseminated intravascular coagulation and in ten patients with cirrhosis. Residual activity in those plasmas appeared qualitatively normal, and no inhibitor (platelet factor IV activity) was observed. Plasmas from patients with disseminated intravascular coagulation and cirrhosis required more heparin to obtain in vitro clotting time prolongation equivalent to normal.This publication has 5 references indexed in Scilit:
- Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc ElectrophoresisScandinavian Journal of Clinical and Laboratory Investigation, 1968
- Antithrombin III and DiseasesAmerican Journal of Clinical Pathology, 1967
- OBSERVATIONS ON THROMBIN INACTIVATION BY HUMAN SERUMThe Journal of general physiology, 1953
- Fundamental Interactions and Effect of Storage, Ether, Adsorbants and Blood Clotting on Plasma Antithrombin ActivityAmerican Journal of Physiology-Legacy Content, 1952
- Serum and Plasma Antithrombin.Experimental Biology and Medicine, 1948